Stocktoria
Century Therapeutics, Inc. IPSC
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-06-17
Century Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 5,964,678 | $13.5M | 6.82% |
| MILLENNIUM MANAGEMENT LLC | 4,667,063 | $10.5M | 5.33% |
| BlackRock Finance, Inc. | 2,895,613 | $7.4M | 3.31% |
| TWO SIGMA INVESTMENTS, LP | 2,371,430 | $5.4M | 2.71% |
| RENAISSANCE TECHNOLOGIES LLC | 906,827 | $2.0M | 1.04% |
| CITADEL ADVISORS LLC | 13,100 | $29,606 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.